Overview
Dr. Labaki is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and the Medical Director of the Lung Volume Reduction Program at the University of Michigan. He earned his medical degree from Georgetown University, and completed his residency in Internal Medicine at the Johns Hopkins Hospital and his fellowship in Pulmonary and Critical Care Medicine at the University of Michigan. He also earned a Master’s Degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health.Dr. Labaki is a provider in the multidisciplinary COPD Clinic and a member of the COPD Quality Improvement Committee at the University of Michigan. He conducts clinical and translational research in COPD, including its epidemiology, natural history, chest imaging biomarkers, and more recently metabolomics. He is also involved in the institutional operations of several NIH-sponsored COPD studies and clinical trials. In 2019, Dr. Labaki was the recipient of the Sreedhar Nair Early Stage Investigator Award in COPD from the American Thoracic Society. He sits on the Editorial Board of the Journal of the COPD Foundation and is an active member of the American Thoracic Society, European Respiratory Society and the Metabolomics Association of North America.
Dr. Labaki is highly rated in 5 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Lung Metastases, Cystic Fibrosis, and Endoscopy.
His clinical research consists of co-authoring 91 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor 3 Reception C, Ann Arbor, MI 48109
Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Labaki has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Taubman Center
Director of the Michigan Medicine Interstitial Lung Disease program, Vice-Chair of the Medical School Institutional Review Board for Human Subjects Research, Associate Program Director Internal Medicine Residency Program - Research, Co-Director University of Michigan Medical School Scientific Discovery Pathway, Steering committee chair for the pulmonary fibrosis foundations Care Center Network and Patient Registry. Dr. Flaherty is highly rated in 13 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant.
Taubman Center
Justin Oldham is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Ann Arbor, Michigan. Dr. Oldham is highly rated in 10 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, and Lung Transplant.
University Of Michigan Medical Center
Eric White is a Pulmonary Medicine provider in Ann Arbor, Michigan. Dr. White is highly rated in 10 conditions, according to our data. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.
Frequently Asked Questions about Dr. Wassim W. Labaki
How do I make an appointment with Dr. Wassim W. Labaki?
You can book an appointment with Dr. Wassim W. Labaki by calling their office at 888-287-1084. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Wassim W. Labaki a top-rated expert for Chronic Obstructive Pulmonary Disease (COPD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Wassim W. Labaki is classified as an Elite expert for Chronic Obstructive Pulmonary Disease (COPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Wassim W. Labaki specialize in?
While Dr. Wassim W. Labaki is a Pulmonary Medicine, they have specific expertise in Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Lung Metastases. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Wassim W. Labaki participate in research or clinical trials?
Yes. Dr. Wassim W. Labaki has published 91 articles and abstracts on conditions like Chronic Obstructive Pulmonary Disease (COPD). You can view a list of Dr. Wassim W. Labaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Wassim W. Labaki accept my insurance?
Dr. Wassim W. Labaki accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 888-287-1084 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Obstructive Pulmonary Disease (COPD)
- EmphysemaDr. Labaki isElite. Learn about Emphysema.
- Advanced
- BronchitisDr. Labaki isAdvanced. Learn about Bronchitis.
- Cystic FibrosisDr. Labaki isAdvanced. Learn about Cystic Fibrosis.
- Lung MetastasesDr. Labaki isAdvanced. Learn about Lung Metastases.
- Experienced
- Acute Interstitial PneumoniaDr. Labaki isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute Respiratory Distress Syndrome (ARDS)
- Allergic Bronchopulmonary AspergillosisDr. Labaki isExperienced. Learn about Allergic Bronchopulmonary Aspergillosis.
- Alpha-1 Antitrypsin Deficiency (AATD)Dr. Labaki isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- AspergillosisDr. Labaki isExperienced. Learn about Aspergillosis.
- BronchiectasisDr. Labaki isExperienced. Learn about Bronchiectasis.